According to Dentsply Sirona 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.64978. At the end of 2024 the company had a P/E ratio of -4.17.
Year | P/E ratio | Change |
---|---|---|
2024 | -4.17 | -92.85% |
2023 | -58.3 | 713.59% |
2022 | -7.17 | -123.27% |
2021 | 30.8 | -123.55% |
2020 | -131 | -372.95% |
2019 | 48.0 | -677.4% |
2018 | -8.31 | -13.19% |
2017 | -9.57 | -133.65% |
2016 | 28.4 | -15.88% |
2015 | 33.8 | 44.06% |
2014 | 23.5 | 6.01% |
2013 | 22.1 | 24.07% |
2012 | 17.8 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() Integra LifeSciences IART | -34.6 | 849.32% | ๐บ๐ธ USA |
![]() Align Technology
ALGN | 36.5 | -1,100.53% | ๐บ๐ธ USA |
![]() Biolase
BIOL | -0.0011 | -99.97% | ๐บ๐ธ USA |
![]() Danaher DHR | 38.7 | -1,160.90% | ๐บ๐ธ USA |
![]() 3M MMM | 19.6 | -637.57% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.